4 ms·
In particular it's not only brand name medications, but patented ones, because then there is by law only one supplier, and the temporarily high price is on purp
by AnthonyMouse 6y ago
In particular it's not only brand name medications, but patented ones, because then there is by law only one supplier, and the temporarily high price is on purpose as a reward for developing the new drug.
The problem we have then is that it's getting paid for by insurance, and we don't have a good mechanism to distinguish between essential things and merely new things. If somebody comes up with the cure for cancer, letting them soak the insurance companies for 20 years is a fair trade. If somebody comes up with a pill that does the same thing as the combination of two pills that had been standard practice previously, but can convince doctors to prescribe the new thing, letting them soak the insurance companies for 20 years is some kind of regulatory failure.
- vikramkr 6y agoWell actually, the only patent prescription drug is a bit elastic since insurance/PBMs negotiate on price. In referring to the particular case of a formerly on patent brand name drug that goes off patent that spikes in price. You'll notice that even over the counter non patented brand name drugs are more expensive than the generics - brand loyalty breeds inelasticity